BACKGROUND: Inflammation biomarkers are associated with the venous thromboembolism (VTE) risk factors obesity and age; however, the relationships of inflammation with VTE risk remain controversial. OBJECTIVES: To examine associations of four inflammation biomarkers, i.e. C-reactive protein (CRP), serum albumin, white blood cell (WBC) count, and platelet count (PLTC), with incident VTE, and to determine whether they mediate the association of age or obesity with VTE. PATIENTS/ METHODS: Hazards models adjusted for VTE risk factors were used to calculate the prospective association of each biomarker with incident VTE in 30,239 participants of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Mediation of the associations of obesity and age with VTE were examined by bootstrapping. Over a period of 4.6 years, there were 268 incident VTE events. After adjustment for VTE risk factors, the hazard ratios (HRs) were 1.25 (95% confidence interval [CI] 1.09-1.43) per standard deviation (SD) higher log-CRP and 1.25 (95% CI 1.06-1.48) per SD lower albumin; there were no associations for WBC count or PLTC. The association of body mass index (BMI), but not age, with VTE was partially mediated by CRP and albumin. In risk factor-adjusted models, the percentage attenuations of the BMI HR for VTE after introduction of CRP or albumin into the models were 15.4% (95% CI 7.7-33.3%) and 41.0% (95% CI 12.8-79.5%), respectively. CONCLUSION: Higher CRP levels and lower serum albumin levels were associated with increased VTE risk, and statistically mediated part of the association of BMI with VTE. These data suggest that inflammation may be a potential mechanism underlying the relationship between obesity and VTE risk.
BACKGROUND:Inflammation biomarkers are associated with the venous thromboembolism (VTE) risk factors obesity and age; however, the relationships of inflammation with VTE risk remain controversial. OBJECTIVES: To examine associations of four inflammation biomarkers, i.e. C-reactive protein (CRP), serum albumin, white blood cell (WBC) count, and platelet count (PLTC), with incident VTE, and to determine whether they mediate the association of age or obesity with VTE. PATIENTS/ METHODS: Hazards models adjusted for VTE risk factors were used to calculate the prospective association of each biomarker with incident VTE in 30,239 participants of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Mediation of the associations of obesity and age with VTE were examined by bootstrapping. Over a period of 4.6 years, there were 268 incident VTE events. After adjustment for VTE risk factors, the hazard ratios (HRs) were 1.25 (95% confidence interval [CI] 1.09-1.43) per standard deviation (SD) higher log-CRP and 1.25 (95% CI 1.06-1.48) per SD lower albumin; there were no associations for WBC count or PLTC. The association of body mass index (BMI), but not age, with VTE was partially mediated by CRP and albumin. In risk factor-adjusted models, the percentage attenuations of the BMI HR for VTE after introduction of CRP or albumin into the models were 15.4% (95% CI 7.7-33.3%) and 41.0% (95% CI 12.8-79.5%), respectively. CONCLUSION: Higher CRP levels and lower serum albumin levels were associated with increased VTE risk, and statistically mediated part of the association of BMI with VTE. These data suggest that inflammation may be a potential mechanism underlying the relationship between obesity and VTE risk.
Authors: Radjesh J Bisoendial; John J P Kastelein; Johannes H M Levels; Jaap J Zwaginga; Bas van den Bogaard; Pieter H Reitsma; Joost C M Meijers; Daniel Hartman; Marcel Levi; Erik S G Stroes Journal: Circ Res Date: 2005-03-17 Impact factor: 17.367
Authors: Walter Stefan Speidl; Andrea Zeiner; Mariam Nikfardjam; Alexander Geppert; Nelli Jordanova; Alexander Niessner; Gerlinde Zorn; Gerald Maurer; Wolfgang Schreiber; Johann Wojta; Kurt Huber Journal: J Am Coll Cardiol Date: 2005-01-04 Impact factor: 24.094
Authors: J G van der Bom; S R Heckbert; T Lumley; C E Holmes; M Cushman; A R Folsom; F R Rosendaal; B M Psaty Journal: J Thromb Haemost Date: 2008-12-20 Impact factor: 5.824
Authors: Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn Journal: N Engl J Med Date: 2008-11-09 Impact factor: 91.245
Authors: Robert J Glynn; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Paul M Ridker Journal: N Engl J Med Date: 2009-03-29 Impact factor: 91.245
Authors: Bakhtawar K Mahmoodi; Ron T Gansevoort; Nic J G M Veeger; Abigail G Matthews; Gerjan Navis; Hans L Hillege; Jan van der Meer Journal: JAMA Date: 2009-05-06 Impact factor: 56.272
Authors: Sverre C Christiansen; Inger Anne Naess; Suzanne C Cannegieter; Jens Hammerstrøm; Frits R Rosendaal; Pieter H Reitsma Journal: PLoS Med Date: 2006-08 Impact factor: 11.069
Authors: Mary Cushman; Ellen S O'Meara; Susan R Heckbert; Neil A Zakai; Wayne Rosamond; Aaron R Folsom Journal: Thromb Res Date: 2016-06-15 Impact factor: 3.944
Authors: Sara Lindström; Marine Germain; Marta Crous-Bou; Erin N Smith; Pierre-Emmanuel Morange; Astrid van Hylckama Vlieg; Hugoline G de Haan; Daniel Chasman; Paul Ridker; Jennifer Brody; Mariza de Andrade; John A Heit; Weihong Tang; Immaculata DeVivo; Francine Grodstein; Nicholas L Smith; David Tregouet; Christopher Kabrhel Journal: Hum Genet Date: 2017-05-20 Impact factor: 4.132
Authors: K L Cheung; N A Zakai; P W Callas; G Howard; B K Mahmoodi; C A Peralta; S E Judd; M Kurella Tamura; M Cushman Journal: J Thromb Haemost Date: 2018-08-09 Impact factor: 5.824
Authors: Oliver Königsbrügge; Florian Posch; Julia Riedl; Eva-Maria Reitter; Christoph Zielinski; Ingrid Pabinger; Cihan Ay Journal: Oncologist Date: 2016-01-13
Authors: J X Moore; N A Zakai; M Mahalingam; R L Griffin; M R Irvin; M M Safford; J W Baddley; H E Wang Journal: J Thromb Haemost Date: 2016-09-23 Impact factor: 5.824